ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
9 announcements with these filters
Religare Enterprises Limited held its 42nd Annual General Meeting on September 24, 2026, where members adopted financial statements and approved the re-designation of Mr. Arjun Lamba.
Religare Enterprises' subsidiary, Care Health Insurance Limited, has allotted non-convertible debentures aggregating to ₹100 Crore. These securities will be listed on the NSE.
Religare Enterprises Limited has approved the continuation of Mr. Rajender Mohan Malla as the Non-Executive Chairperson for the quarter ending December 31, 2026.
Religare Q1FY27 shows strategic focus on core segments. Consolidated revenue grew 26% YoY to ₹2,358 Cr, though PAT remains negative at ₹46.9 Cr due to reporting standard transitions and investment modes.
Religare reported Q1 FY27 consolidated revenue of Rs. 2,358.4 Cr, up 26% YoY, driven by strong performance in the Insurance segment. Net profit turned into a loss of Rs. 46.9 Cr.
Religare Enterprises Ltd reported revenue from operations of ₹2.5 Cr (+1150.0% YoY) and a net loss of ₹9.6 Cr for Q1 FY27.
Religare Enterprises Ltd reported revenue from operations of ₹2,353 Cr (+25.7% YoY) and a net loss of ₹47 Cr for Q1 FY27.
Religare Enterprises reported FY26 consolidated total income of ₹8,493cr and PAT of ₹73.16cr. Management is restructuring via demerger into two listed entities: Health Insurance and Financial Services.
Religare Enterprises Ltd reported revenue from operations of ₹2,467 Cr (+20.8% YoY) and net profit of ₹95.7 Cr (-36.5% YoY) for Q4 FY26.